RSF-1, remodeling and spacing factor 1, engaged in DNA damage repair and cell apoptosis, was reported to reduce cisplatin resistance in malignant melanoma [33] and nasopharyngeal carcinoma [24]. This evidence concerns the gene RSF1 and nasopharyngeal carcinoma.